Advertisement

Topics

R&D Market Pulse: Pharma Gets Boost; France Bans Oil & Gas Exploration

10:30 EDT 28 Jun 2017 | R&D Magazine

Novartis saw a particularly significant increase in the stock market, gaining nearly 7%, mostly due to positive phase III results from its CANTOS study.
Staff Author: 

Original Article: R&D Market Pulse: Pharma Gets Boost; France Bans Oil & Gas Exploration

NEXT ARTICLE

More From BioPortfolio on "R&D Market Pulse: Pharma Gets Boost; France Bans Oil & Gas Exploration"

Quick Search
Advertisement
 

Relevant Topics

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...